Lin Wen-Yun, Wang Jin-Jhe, Lai Chien-Hsiung
School of Medicine, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
Department of Ophthalmology, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan.
Vaccines (Basel). 2022 Jun 10;10(6):931. doi: 10.3390/vaccines10060931.
People are advised to receive a vaccine booster as the Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerge, but various adverse ocular reactions after vaccination have been reported. NAION following COVID-19 vaccination appears extremely rarely. Here, we report a case of a 61-year-old female with sudden painless blurred vision developing NAION after receiving ChAdOx1 nCoV-19 (AstraZeneca) vaccination and provide an in-depth explanation of the possible mechanisms regarding the hypercoagulable state after vaccination. Our report adds to the literature on potential adverse ocular effects after COVID-19 vaccination, and we as ophthalmologists recommend that clinicians should increase awareness of this possible ocular complication when evaluating patients with sudden visual disturbance with a recent history of vaccination.
随着严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的德尔塔和奥密克戎变种出现,建议人们接种疫苗加强针,但接种疫苗后出现了各种不良眼部反应。接种新冠疫苗后发生非动脉炎性前部缺血性视神经病变(NAION)极为罕见。在此,我们报告一例61岁女性在接种ChAdOx1 nCoV-19(阿斯利康)疫苗后突然出现无痛性视力模糊并发生NAION的病例,并深入解释接种疫苗后高凝状态的可能机制。我们的报告补充了关于新冠疫苗接种后潜在不良眼部影响的文献,作为眼科医生,我们建议临床医生在评估近期有疫苗接种史且突发视力障碍的患者时,应提高对这种可能的眼部并发症的认识。